Construct Validity of the Questionnaire on Experience with Skin Complaints (Short Form)
Abstract
Abstract.Introduction: Feelings of stigmatization can strongly influence quality of life in individuals with chronic skin diseases. The Short-Form of the Questionnaire on Experience with Skin Complaints (SF-QES) differentiates four factors of stigmatization: self-esteem and retreat, experienced refusal, concealment, and composure. The current study aimed to investigate the construct validity of the SF-QES. Method: The analysis was based on the complete SF-QES records of a clinical psoriasis trial, which yielded 1,005 records at baseline, 1,010 records at the end of therapy, and 885 and 827 records, respectively, at two follow-ups. Factor analyses and corresponding structural equation models (SEMs) using robust maximum likelihood estimation (RML) were applied. Additionally, the responsiveness of the scales to judgments of treatment success and two different interventions were compared. Results: The factor analyses provided results that widely agreed with the supposed four factors. SEM, however, showed moderately insufficient fit for this model, but supported five factors and the discrimination between affected self-esteem and retreat. The retreat scale was clearly most responsive to treatment success and intervention type. Conclusion: The construct validity of the SF-QES was largely supported, but the factor retreat should be separated from affected self-esteem and is most sensitive to physical intervention.
References
Boomsma, A. Hoogland, J. (2001). The robustness of LISREL modeling revisited. In R. Cudeck, S. du Toit, & D. Sörbom (Eds.), Structural equation modeling. A Festschrift in honor of Karl Jöreskog (pp. 139-168). Chicago: Scientific Software InternationalFortune, D.G. Richards, H.L. Kirby, B. McElhone, K. Markham, T. Rogers, S. et al. (2003). Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Archives of Dermatology, 139, 752– 756Fredriksson, T. Pettersson, U. (1978). Severe psoriasis - oral therapy with a new retinoid. Dermatologica, 157, 238– 244Ginsburg, I.H. Link, B.G. (1989). Feelings of stigmatization in patients with psoriasis. Journal of the American Academy of Dermatology, 20(1), 53– 63Hu, L.T. Bentler, P.M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6(1), 1– 55Jöreskog, K.G. Sörbom, D. (1996). LISREL 8 user's reference guide . Lincolnwood, IL: Scientific Software InternationalMoustaki, I. Joreskog, K. (2001). Factor analysis for ordinal variables: A comparison of three approaches. Multivariate Behavioural Research, 36, 347– 387Rapp, S.R. Feldman, S.R. Exum, M.L. Fleischer, A.B.J. Reboussin, D.M. (1999). Psoriasis causes as much disability as other major medical diseases. Journal of the American Academy of Dermatology, 41, 401– 407Schmid-Ott, G. Burchard, R. Niederauer, H.H. Lamprecht, F. Künsebeck, H.W. (2003). Stigmatisierung und Lebensqualität bei Patienten mit Psoriasis und Neurodermitis [Stigmatization and quality of life in patients with psoriasis and atopic dermatitis]. Der Hautarzt, 54, 852– 857Schmid-Ott, G. Jäger, B. Künsebeck, H.W. Ott, R. Lamprecht, F. (1996). Dimensions of stigmatization in patients with psoriasis in a Questionnaire on Experience with Skin Complaints. Dermatology, 193, 304– 310Schmid-Ott, G. Jäger, B. Künsebeck, H.-W. Ott, R. Wedderer, K. Lamprecht, F. (1998). Entwicklung des “Fragebogens zum Erleben von Hautbeschwerden” (FEH): Faktorenanalyse und Untersuchung von Prädiktoren für das Krankheitserleben von Psoriasis-Patienten [Development of the Questionnaire on Experience of Skin Complaints (QES): Factor analysis and investigation of predictors for illness experience of psoriasis patients]. Zeitschrift für Klinische Psychologie, Psychiatrie und Psychotherapie, 46, 330– 344Schmid-Ott, G. Künsebeck, H.-W. Jäger, B. Sittig, U. Hofste, N. Ott, R. et al. (2005). Significance of the stigmatization experience of psoriasis patients: A 1-year follow-up of the illness and its psychosocial consequences. Acta Dermato-Venereologica, 85, 27– 32Schmid-Ott, G. Künsebeck, H.W. Jäger, B. Werfel, T. Frahm, K. Ruitman, J. et al. (1999). Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients. Acta Dermato-Venereologica, 79, 443– 447Stangier, U. Ehlers, A. Gieler, U. (2003). Measuring adjustment to chronic skin disorders: Validation of a self-report measure. Psychological Assessment, 15, 532– 549Vardy, D. Besser, A. Amir, M. Gesthalter, B. Biton, A. Buskila, D. (2002). Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. British Journal of Dermatology, 147, 736– 742Yuan, K.-H. Bentler, P.M. Zhang, W. (2005). The effect of skewness and kurtosis on mean and covariance structure analysis. The univariate case and its multivariate implication. Sociological Methods and Research, 34, 240– 258
